Cargando…
Targeting intrinsic RIG-I signaling turns melanoma cells into type I interferon-releasing cellular antitumor vaccines
Resistance to cell death and evasion of immunosurveillance are major causes of cancer persistence and progression. Tumor cell-intrinsic activation of the RNA receptor retinoic acid-inducible gene-I (RIG-I) can trigger an immunogenic form of programmed tumor cell death, but its impact on antitumor re...
Autores principales: | Bek, Sarah, Stritzke, Florian, Wintges, Alexander, Nedelko, Tatiana, Böhmer, Daniel F.R., Fischer, Julius C., Haas, Tobias, Poeck, Hendrik, Heidegger, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422402/ https://www.ncbi.nlm.nih.gov/pubmed/30906666 http://dx.doi.org/10.1080/2162402X.2019.1570779 |
Ejemplares similares
-
RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
por: Heidegger, Simon, et al.
Publicado: (2019) -
Targeting RIG-I or STING promotes epithelial regeneration
por: Fischer, Julius C., et al.
Publicado: (2017) -
P57. Activation of RIG-I induces immunogenic cell death
por: Bek, S, et al.
Publicado: (2014) -
Card9 controls Dectin‐1‐induced T‐cell cytotoxicity and tumor growth in mice
por: Haas, Tobias, et al.
Publicado: (2017) -
RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury
por: Fischer, Julius C., et al.
Publicado: (2017)